CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 40,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 72,000 shares (grant or award)
- 4 Grant or award President acquired 62,215 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 49,450 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Financial Officer acquired 7,857 shares (option exercise)
- 4 Open-market sale Director sold 8,000 shares at $8.00 ($64,000)
- 4 Option exercise Director acquired 4,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 10,000 shares (option exercise)
- 4 Option exercise President and COO acquired 10,123 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 14,100 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 140,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 10,000 shares at $10.00 ($100,000)
- 4 Open-market sale Chief Operating Officer sold 4,677 shares at $6.00 ($28,062)
- 4 Grant or award Chief Operating Officer acquired 54,100 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 6 of 20 · 395 filings